Lilly To Offer Direct-To-Employer Programs
Eli Lilly and Co. is preparing a new direct-to-employer model that will allow companies to offer coverage for its obesity medications, including Zepbound, beginning in early 2026.
Read MoreTag Archives: Diabetes
Roche Announces $550 Million Indianapolis Investment
Roche Diagnostics announced it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030.
Read More
Increased Prevention and Treatment Needed for Common Cardiovascular Condition
The prevalence of one of the most common cardiovascular conditions in the U.S. is significantly higher than previously estimated, underscoring the need for better prevention and treatment strategies.
Read More
Diabetes drug could help Indiana residents ease COVID symptoms
The aftermath of COVID-19 infections has left many with unexplainable fatigue or memory loss.
Read MoreInsulin Pump Recall: Medtronic Notifies Users of MiniMed 600 and 700 Series Pumps of Risk of Shorter than Expected Battery Life
Medtronic is notifying users of MiniMed 600 and 700 series insulin pumps of an increased risk for reduced battery life and less time until shutdown after a battery alert occurs.
Read More
New Weight-Loss Drug Announces Positive Results of Human Adipose Tissue Study
Adipo Therapeutics, LLC, a late pre-clinical biopharmaceutical company developing treatments for obesity and related metabolic disorders, announced the positive results for a key study demonstrating promising results using human tissue samples.
Read MoreVirtual Dining With Diabetes Cooking Classes Offered By Purdue Extension
Diabetes affects over 30 million people in the Unites States, according to data estimates by the Centers for Disease Control and Prevention, which means that nearly 10 percent of the United States population is diabetic. Â
Read More